Despite the communication gurus, I don't think there is a good way to pass along bad news. This week's news is not as bad as it could be, but it's bad enough.
The chemo Elizabeth has been getting is for a particular type of PTLD. The results from the biopsy show that her lymphoma is a different type which doesn't respond to her treatment.
There are a few treatment options left. One is a transfusion of T cells from the original donor. Unfortunately, the donor had pulled out of the program.
There's a similar treatment in clinical trial at Sloan-Kettering in New York. It's for people who can't use the original donor's T cells. She has been accepted, but she has to cover travel, lodging and other medical expenses. There are funds available from the province, but she has to go through the approval province. This takes time, and that is in short supply.
If these options don't work, they can give her a modified version of a full chemo treatment. She's not strong enough to handle the full dosage.
No comments:
Post a Comment